The government seems to be having a hard time embracing medical cannabis and legalizing it. Could it be because of big pharmaceutical companies?
According to a 2017 study by New Frontier Data, Big Pharma stands to lose $4 billion if medical cannabis is legalized. And that’s just the conservative estimate.
Why is this so? Because anecdotal evidence shows that medical cannabis is effective in treating a wide array of medical conditions and symptoms — including chronic pain, PTSD, and epilepsy.
So you can just imagine the multitude of patients who would turn to cannabis instead of keeping their prescription opioids and other pharmaceutical drugs! This is because pot is relatively way cheaper than most of these prescription medications.
Cannabis is also a lot safer and more effective. Pharmaceutical drugs are known to carry with them a host of side effects. Some may be effective at helping patients manage their pain, but they may be highly addictive. Many prescription opioids for chronic pain have also been found to cause depression.
Anyway, here’s a short video explaining why large pharmaceutical firms oppose the legalization of medical cannabis: